Cardiff Oncology (CRDF) Cost of Revenue (2016 - 2018)
Historic Cost of Revenue for Cardiff Oncology (CRDF) over the last 6 years, with Q3 2018 value amounting to $26677.0.
- Cardiff Oncology's Cost of Revenue fell 9436.24% to $26677.0 in Q3 2018 from the same period last year, while for Jun 2019 it was $26677.0, marking a year-over-year decrease of 9813.13%. This contributed to the annual value of $597457.0 for FY2018, which is 6701.73% down from last year.
- Per Cardiff Oncology's latest filing, its Cost of Revenue stood at $26677.0 for Q3 2018, which was down 9436.24% from $204436.0 recorded in Q2 2018.
- Cardiff Oncology's Cost of Revenue's 5-year high stood at $3.1 million during Q2 2016, with a 5-year trough of $26677.0 in Q3 2018.
- For the 5-year period, Cardiff Oncology's Cost of Revenue averaged around $1.2 million, with its median value being $616426.0 (2017).
- In the last 5 years, Cardiff Oncology's Cost of Revenue skyrocketed by 28476.57% in 2016 and then plummeted by 9436.24% in 2018.
- Quarter analysis of 5 years shows Cardiff Oncology's Cost of Revenue stood at $1.0 million in 2014, then surged by 86.95% to $1.9 million in 2015, then increased by 23.82% to $2.4 million in 2016, then crashed by 83.99% to $383593.0 in 2017, then crashed by 93.05% to $26677.0 in 2018.
- Its last three reported values are $26677.0 in Q3 2018, $204436.0 for Q2 2018, and $366344.0 during Q1 2018.